These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11020857)

  • 21. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
    Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
    Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
    Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y
    Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients.
    Rea DJ; Munoz-Juarez M; Farnell MB; Donohue JH; Que FG; Crownhart B; Larson D; Nagorney DM
    Arch Surg; 2004 May; 139(5):514-23; discussion 523-5. PubMed ID: 15136352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma.
    Aishima S; Taguchi K; Terashi T; Matsuura S; Shimada M; Tsuneyoshi M
    Mod Pathol; 2003 Oct; 16(10):1019-27. PubMed ID: 14559985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
    Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
    J Surg Oncol; 2007 Aug; 96(2):160-5. PubMed ID: 17443744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic study of cholangiocarcinoma with superficial spread.
    Igami T; Nagino M; Oda K; Nishio H; Ebata T; Yokoyama Y; Shimoyama Y
    Ann Surg; 2009 Feb; 249(2):296-302. PubMed ID: 19212185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence of intrahepatic cholangiocarcinoma nine years after surgical resection.
    Kitagawa D; Taketomi A; Aishima S; Kuroda Y; Gion T; Shirabe K; Shimada M; Maehara Y
    Hepatogastroenterology; 2008; 55(84):1085-8. PubMed ID: 18705334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A long-term survivor of intrahepatic cholangiocarcinoma with lymph node metastasis: a case report.
    Yamamoto M; Takasaki K; Imaizumi T; Ariizumi S; Matsumura N; Nakano M
    Jpn J Clin Oncol; 2002 Jun; 32(6):206-9. PubMed ID: 12110637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
    Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma.
    Nanashima A; Sumida Y; Abo T; Oikawa M; Murakami G; Takeshita H; Fukuoka H; Hidaka S; Nagayasu T; Sakamoto I; Sawai T
    J Surg Oncol; 2008 Dec; 98(7):535-9. PubMed ID: 18814285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
    Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
    Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrahepatic cholangiocarcinoma with sarcomatous change. Clinicopathologic and immunohistochemical evaluation of seven cases.
    Nakajima T; Tajima Y; Sugano I; Nagao K; Kondo Y; Wada K
    Cancer; 1993 Sep; 72(6):1872-7. PubMed ID: 7689920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
    Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD
    Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic hepatectomy and dissection of lymph nodes for intrahepatic cholangiocarcinoma. Case report.
    Harimoto N; Shimada M; Tsujita E; Maehara S; Rikimaru T; Yamashita Y; Maeda T; Tanaka S; Shirabe K; Sugimachi K
    Surg Endosc; 2002 Dec; 16(12):1806. PubMed ID: 12239645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
    Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical management and prognostic factors of hilar cholangiocarcinoma: experience with 115 cases in China.
    Yubin L; Chihua F; Zhixiang J; Jinrui O; Zixian L; Jianghua Z; Ye L; Haosheng J; Chaomin L
    Ann Surg Oncol; 2008 Aug; 15(8):2113-9. PubMed ID: 18546046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy.
    Yeh CN; Pang ST; Wu RC; Chen TW; Jan YY; Chen MF
    Oncol Rep; 2009 Jan; 21(1):49-56. PubMed ID: 19082442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors of intrahepatic cholangiocarcinoma after surgical treatment.
    Kinoshita H; Tanimura H; Uchiyama K; Tani M; Onishi H; Yamaue H
    Oncol Rep; 2002; 9(1):97-101. PubMed ID: 11748464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma.
    Tajima Y; Kuroki T; Fukuda K; Tsuneoka N; Furui J; Kanematsu T
    Br J Surg; 2004 Jan; 91(1):99-104. PubMed ID: 14716802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.